addenda and errata\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

5-(1,3-Benzodioxol-5-yl)-3-methyl-1,7-di­phenyl-1,6,7,8-tetra­hydro­pyrazolo[3,4-b][1,4]­diazepine. Addendum

CROSSMARK_Color_square_no_text.svg

aDepartment of Chemistry, University of Aberdeen, Meston Walk, Old Aberdeen, AB24 3UE, Scotland, bGrupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, AA25360 Cali, Colombia, cDepartamento de Química, Universidad del Nariño, Ciudad Universitaria Torobajo, Pasto, Colombia, and dDepartamento de Química Inorgánica y Orgánica, Universidad de Jaén, 23071 Jaén, Spain
*Correspondence e-mail: j.n.low@abdn.ac.uk

(Received 1 June 2003; accepted 2 June 2003; online 10 July 2003)

In the paper by Low et al. [Acta Cryst. (2003), E59, o614–o615], the title compound is better described as a racemate, viz. (7RS)-5-(1,3-benzodioxol-5-yl)-3-methyl-1,7-di­phenyl-1,6,7,8-tetra­hydro­pyrazolo[3,4-b][1,4]­diazepine.

Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds